(HOTH) Hoth Therapeutics - Performance 63.6% in 12m
HOTH performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-64.82%
#138 in Peer-Group
Rel. Strength
90.21%
#751 in Stock-Universe
Total Return 12m
63.64%
#19 in Peer-Group
Total Return 5y
-97.71%
#185 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 2.28 USD |
| 52 Week Low | 0.59 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 94.69 |
| Buy/Sell Signal +-5 | -1.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: HOTH (63.6%) vs XLV (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
2.6% | 122% | 354% | 62.6 | 55.3 | 0.61 | 23.7% | -5.15% |
| NVS NYSE Novartis |
1.31% | 13.6% | 82% | 19.4 | 14.7 | 1.44 | 8.70% | 9.2% |
| LLY NYSE Eli Lilly |
-3.22% | -16% | 419% | 64.5 | 36.4 | 1.21 | 58.2% | 18.9% |
| NOVN SW Novartis |
-0.96% | 0.58% | 50.8% | 19.5 | 14.7 | 1.44 | 8.70% | 9.2% |
| GSK NYSE GlaxoSmithKline |
-6.31% | 3.35% | 50.2% | 19.1 | 8.73 | 0.38 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
-4.42% | -7.1% | 49.9% | 27.9 | 15.4 | 0.93 | 72.4% | 45.1% |
| SFZN SW Siegfried Holding |
-4.46% | -8.98% | 106% | 24.2 | 23.6 | 1.48 | -42.4% | -29.3% |
| UCB BR UCB |
4.59% | 19.6% | 62.6% | 31.1 | 22 | 1.04 | -22.4% | 39.5% |
Performance Comparison: HOTH vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for HOTH
| Total Return (including Dividends) | HOTH | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 10.77% | -0.22% | 4.77% |
| 3 Months | 74.55% | -1.95% | 16.02% |
| 12 Months | 63.64% | -6.94% | 12.44% |
| 5 Years | -97.71% | 44.47% | 112.73% |
| Trend Score (consistency of price movement) | HOTH | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -4% | 32.3% | 90.3% |
| 3 Months | 81.4% | -15.4% | 97.5% |
| 12 Months | 47.2% | -78.9% | 46.4% |
| 5 Years | -96.9% | 87.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th74.00 | 11.01% | 5.73% |
| 3 Month | %th89.00 | 78.02% | 50.45% |
| 12 Month | %th91.50 | 75.85% | 45.53% |
| 5 Years | %th8.00 | -98.41% | -98.92% |
FAQs
Does Hoth Therapeutics (HOTH) outperform the market?
Yes,
over the last 12 months HOTH made 63.64%, while its related Sector, the Health Care Sector SPDR (XLV) made -6.94%.
Over the last 3 months HOTH made 74.55%, while XLV made -1.95%.
Performance Comparison HOTH vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HOTH vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 21.6% | 6% | -31.7% | 51% |
| US NASDAQ 100 | QQQ | 21.6% | 5.5% | -33.7% | 51% |
| German DAX 40 | DAX | 21.2% | 7.7% | -43.8% | 34% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 20.4% | 5.7% | -36.2% | 44% |
| Hongkong Hang Seng | HSI | 20.7% | 6.8% | -53.7% | 29% |
| India NIFTY 50 | INDA | 22.9% | 9.2% | -32.2% | 67% |
| Brasil Bovespa | EWZ | 25.8% | 11.1% | -46.8% | 63% |
HOTH vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 23% | 7.2% | -35% | 40% |
| Consumer Discretionary | XLY | 20.6% | 6% | -24% | 47% |
| Consumer Staples | XLP | 23.6% | 10.3% | -30.8% | 56% |
| Energy | XLE | 18.6% | 8.8% | -24.2% | 63% |
| Financial | XLF | 23% | 6% | -34% | 41% |
| Health Care | XLV | 21.4% | 11% | -20.2% | 71% |
| Industrial | XLI | 21.2% | 5.2% | -37.6% | 42% |
| Materials | XLB | 20.9% | 5.5% | -32.3% | 60% |
| Real Estate | XLRE | 21.8% | 10.6% | -30.2% | 57% |
| Technology | XLK | 21.7% | 3.6% | -36.8% | 54% |
| Utilities | XLU | 21.5% | 8.8% | -35.7% | 42% |
| Aerospace & Defense | XAR | 20.9% | 3.5% | -51.7% | 17% |
| Biotech | XBI | 17.9% | 6.7% | -21.5% | 77% |
| Homebuilder | XHB | 18.5% | -0.6% | -25.1% | 67% |
| Retail | XRT | 21.6% | 4% | -26.9% | 57% |
HOTH vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 21% | 14.4% | -17.8% | 67% |
| Natural Gas | UNG | 23.3% | 19.6% | -5.7% | 61% |
| Gold | GLD | 21.5% | 13% | -49.6% | 26% |
| Silver | SLV | 17.2% | 4.5% | -53.7% | 39% |
| Copper | CPER | 11.2% | -5.2% | -51.3% | 40% |
HOTH vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 22.4% | 11% | -26.4% | 67% |
| iShares High Yield Corp. Bond | HYG | 22.1% | 9.5% | -28.7% | 55% |